Snyder Mark Howard (CIK 0001902866)

Latest company ownership

HALO - HALOZYME THERAPEUTICS, INC.

Role: SVP, CHIEF LEGAL OFFICER

Shares held

5,035

Last filed at

Jun 13, 2025

Confidence Score

49.4

2025Q4

Confidence Score History

2023Q1 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Jun 12, 2025	Jun 13, 2025	HALOZYME THERAPEUTICS, INC.	SVP, CHIEF LEGAL OFFICER	Sell	42.5	-2,711	-8.09%	✗	$147.9K
Feb 23, 2025	Feb 24, 2025	HALOZYME THERAPEUTICS, INC.	SVP, CHIEF LEGAL OFFICER	Sell	42.5	-3,775	-11.70%	✗	$218K
Feb 16, 2025	Feb 18, 2025	HALOZYME THERAPEUTICS, INC.	SVP, CHIEF LEGAL OFFICER	Sell	40.0	-11,955	-19.84%	✗	$696.9K
Jan 3, 2025	Jan 6, 2025	HALOZYME THERAPEUTICS, INC.	SVP, CHIEF LEGAL OFFICER	Sell	42.5	-4,289	-22.23%	✗	$204.8K
Feb 16, 2024	Feb 20, 2024	HALOZYME THERAPEUTICS, INC.	SVP, GENERAL COUNSEL	Sell	42.5	-2,577	-18.08%	✗	$93K
Jan 3, 2024	Jan 5, 2024	HALOZYME THERAPEUTICS, INC.	SVP, GENERAL COUNSEL	Sell	42.5	-2,957	-23.81%	✗	$105.8K
Jan 3, 2023	Jan 4, 2023	HALOZYME THERAPEUTICS, INC.	SVP, GENERAL COUNSEL	Sell	42.5	-2,804	-36.84%	✗	$154.6K